SCHEMBL2117935

SCHEMBL2117935

CCOC(=O)n1ccc2ccc(O)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.45
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 3/20 0.44
CA9 Q16790 3/20 0.44
CA14 Q9ULX7 3/20 0.44
MIF P14174 2/20 0.42
PFKFB3 Q16875 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
LPO P22079 4/20 0.41
LMNA P02545 3/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2115772 0.88 CA12 (0.44) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL2117368 0.86 MAPK11 (0.49) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL12531335 0.83 MAPK11 (0.47) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL2117444 0.83 OXER1 (0.55) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL28828329 0.83 ACHE (0.47) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL1752188 0.82 MAPK11 (0.57) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL2117429 0.82 MTNR1A (0.51) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL12529413 0.81 MAPK11 (0.46) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL29820909 0.80 HTR6 (0.46) MAPK11MAPK14KDM4EHSD17B10ALDH1A1
SCHEMBL1373109 0.80 HTR6 (0.46) MAPK11MAPK14KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US claimed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US claimed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP claimed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO claimed
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US disclosed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US disclosed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP disclosed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B MAPK11 1129/4885MAPK14 1944/4885KDM4E 2005/4885
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B MAPK11 1129/4885MAPK14 1944/4885KDM4E 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.